Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC | Biomarker Research
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. Google Scholar …
How COVID mRNA vaccines may make cancer treatments more effective
A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers…
Development and validation of a dynamic nomogram for predicting brain metastasis in stage III NSCLC patients undergoing definitive chemoradiotherapy | BMC Cancer
This study developed and validated a dynamic nomogram model that integrates clinicopathological features (e.g., sex, histology, EGFR status,…
AI Model Finds Gene Targets and Drug Combos to Reprogram Diseased Cells
Credit: FlashMovie/Getty Images Traditional drug discovery has often followed the “one drug, one target” paradigm—developing compounds against individual…
Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests
Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…
Clone copy number diversity is linked to survival in lung cancer
The ALPACA algorithm We introduce ALPACA, an algorithm to infer allele-specific copy-number profiles of every tumour clone, given…